McCaw, Tyler R. http://orcid.org/0000-0003-4097-1111
Li, Mei
Starenki, Dmytro
Liu, Mingyong
Cooper, Sara J. http://orcid.org/0000-0002-9627-0309
Arend, Rebecca C.
Forero, Andres
Buchsbaum, Donald J. http://orcid.org/0000-0003-2797-5847
Randall, Troy D. http://orcid.org/0000-0003-0643-0311
Funding for this research was provided by:
National Cancer Institute (CA216234, CA013148)
Article History
Received: 4 April 2019
Accepted: 7 November 2019
First Online: 12 November 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: All procedures involving animals were performed in accordance with the guidelines of the National Research Council (United States) Committee for the Update of the Guide for the Care and Use of Laboratory Animals and were approved by the University of Alabama at Birmingham Institutional Animal Care and Use Committee (IACUC) in protocol 09854.
: BALB/c mice were purchased from Charles River Laboratories International, Inc. BALB/c.scid mice (CBySmn.CB17-Prkdc<sup>scid</sup>IJ) were purchased from The Jackson Laboratory.
: TS/A murine mammary adenocarcinoma cells were provided by Dr. Roberto S. Accolla, Department of Clinical and Biological Sciences, University of Insubria, Italy. TS/A cells were obtained at passage 22 and passaged two times prior to freezing archival samples. 4T1 cells were purchased from the American Type Culture Collection (ATCC). Samples of 4T1 and TS/A cells were authenticated by IDEXX BioAnalytics: case #23272-2019. All cell lines tested negative for mycoplasma (and 13 other mouse pathogens) via PCR performed by Charles River Research Animal Diagnostic Services.